BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12429741)

  • 1. Casein kinase 2 interacts with cyclin-dependent kinase 11 (CDK11) in vivo and phosphorylates both the RNA polymerase II carboxyl-terminal domain and CDK11 in vitro.
    Trembley JH; Hu D; Slaughter CA; Lahti JM; Kidd VJ
    J Biol Chem; 2003 Jan; 278(4):2265-70. PubMed ID: 12429741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 11(p110) activity in the absence of CK2.
    Sachs NA; Vaillancourt RR
    Biochim Biophys Acta; 2003 Dec; 1624(1-3):98-108. PubMed ID: 14642819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PITSLRE p110 protein kinases associate with transcription complexes and affect their activity.
    Trembley JH; Hu D; Hsu LC; Yeung CY; Slaughter C; Lahti JM; Kidd VJ
    J Biol Chem; 2002 Jan; 277(4):2589-96. PubMed ID: 11709559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK11 complexes promote pre-mRNA splicing.
    Hu D; Mayeda A; Trembley JH; Lahti JM; Kidd VJ
    J Biol Chem; 2003 Mar; 278(10):8623-9. PubMed ID: 12501247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cyclin L1 and L2 interactions with CDK11 and splicing factors: influence of cyclin L isoforms on splice site selection.
    Loyer P; Trembley JH; Grenet JA; Busson A; Corlu A; Zhao W; Kocak M; Kidd VJ; Lahti JM
    J Biol Chem; 2008 Mar; 283(12):7721-32. PubMed ID: 18216018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cyclin-dependent kinase 11 interacts with 14-3-3 proteins.
    Feng Y; Qi W; Martinez J; Nelson MA
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1503-9. PubMed ID: 15883043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FCP1 phosphorylation by casein kinase 2 enhances binding to TFIIF and RNA polymerase II carboxyl-terminal domain phosphatase activity.
    Palancade B; Dubois MF; Bensaude O
    J Biol Chem; 2002 Sep; 277(39):36061-7. PubMed ID: 12138108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110).
    Choi HH; Choi HK; Jung SY; Hyle J; Kim BJ; Yoon K; Cho EJ; Youn HD; Lahti JM; Qin J; Kim ST
    Oncogene; 2014 Jan; 33(1):108-15. PubMed ID: 23178491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHOP transcription factor phosphorylation by casein kinase 2 inhibits transcriptional activation.
    Ubeda M; Habener JF
    J Biol Chem; 2003 Oct; 278(42):40514-20. PubMed ID: 12876286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclin-dependent kinase 11(p46) isoform interacts with RanBPM.
    Mikolajczyk M; Shi J; Vaillancourt RR; Sachs NA; Nelson M
    Biochem Biophys Res Commun; 2003 Oct; 310(1):14-8. PubMed ID: 14511641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
    Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
    Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase 11p110 and casein kinase 2 (CK2) inhibit the interaction between tyrosine hydroxylase and 14-3-3.
    Sachs NA; Vaillancourt RR
    J Neurochem; 2004 Jan; 88(1):51-62. PubMed ID: 14675149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association and regulation of casein kinase 2 activity by adenomatous polyposis coli protein.
    Homma MK; Li D; Krebs EG; Yuasa Y; Homma Y
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5959-64. PubMed ID: 11972058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions.
    Messenger MM; Saulnier RB; Gilchrist AD; Diamond P; Gorbsky GJ; Litchfield DW
    J Biol Chem; 2002 Jun; 277(25):23054-64. PubMed ID: 11940573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell development.
    Li T; Inoue A; Lahti JM; Kidd VJ
    Mol Cell Biol; 2004 Apr; 24(8):3188-97. PubMed ID: 15060143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxyl-terminal domain.
    Mitsui A; Sharp PA
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6054-9. PubMed ID: 10339540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK11
    Du Y; Yan D; Yuan Y; Xu J; Wang S; Yang Z; Cheng W; Tian X; Kan Q
    Cell Cycle; 2019 Feb; 18(4):452-466. PubMed ID: 30722725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1.
    Durand LO; Advani SJ; Poon AP; Roizman B
    J Virol; 2005 Jun; 79(11):6757-62. PubMed ID: 15890914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFIIF-associating carboxyl-terminal domain phosphatase dephosphorylates phosphoserines 2 and 5 of RNA polymerase II.
    Lin PS; Dubois MF; Dahmus ME
    J Biol Chem; 2002 Nov; 277(48):45949-56. PubMed ID: 12351650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.